In a multicenter, randomized, double-blind, placebo-controlled, noninferiority trial, we enrolled 5246 men 45 to 80 years of age who had preexisting or a high risk of cardiovascular disease and who ...
Bempedoic acid, an ATP citrate lyase inhibitor, reduces low-density lipoprotein (LDL) cholesterol levels and is associated with a low incidence of muscle-related adverse events; its effects on ...
CHICAGO--(BUSINESS WIRE)--GE Healthcare today announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid 1 cardiovascular ultrasound systems, which includes new features based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results